TB-500 + BPC-157 Stack Dosage Protocol | PeptideDosages.com

TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol

TB-500 + BPC-157 Stack (5 mg Vials) Dosage Protocol

TB-500 Dosage Chart

TB-500 is dosed at 1.25 mg weekly via subcutaneous injection in educational protocols. A 5 mg reconstituted with bacteriostatic water yields about 2.5 mg/mL. This information is for research and educational use only.

TB-500 Reconstitution: Add 2.0 mL bacteriostatic water → 2.5 mg/mL concentration.

BPC-157 Reconstitution: Add 2.0 mL bacteriostatic water → 2.5 mg/mL concentration.

TB-500 Dosing: 1,250 mcg (50 units) twice weekly (Weeks 1–4), then once weekly (Weeks 5–12).

BPC-157 Dosing: 250–500 mcg (10–20 units) daily, titrated over 12 weeks.

Easy measuring: At 2.5 mg/mL, 1 unit = 0.01 mL = 25 mcg on a U-100 insulin syringe.

Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate and use within ~30 days.

TB-500 (Thymosin β4) is a 43-amino-acid peptide that promotes tissue repair and regeneration through enhanced angiogenesis and cellular migration[1][2]. BPC-157 (Body Protection Compound-157) is a 15-amino-acid gastric peptide studied for accelerating musculoskeletal healing by upregulating growth factor signaling[3][4]. Stacking these peptides is a common research approach for synergistic tissue repair support.

Related research: For distinct compound, component, or formulation evidence and safety context, read BPC-157 Peptide: Benefits, Uses, Side Effects, Dosage, and Research and TB-500 Peptide: Benefits, Uses, Side Effects, Dosage, and Research. These links are comparisons only; the compounds and formulations should not be treated as interchangeable.

TB-500 Protocol (2 mL Reconstitution = 2.5 mg/mL)

Weeks 1–4

1,250 mcg (1.25 mg)

50 units (0.50 mL)

Twice weekly

Weeks 5–12

Once weekly

Route: Subcutaneous injection. The loading phase (Weeks 1–4) uses twice-weekly dosing to establish tissue saturation, followed by a maintenance phase (Weeks 5–12) at once weekly[1].

TB-500 Reconstitution Steps

Draw 2.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

BPC-157 Protocol (2 mL Reconstitution = 2.5 mg/mL)

Weeks 1–2

250 mcg (0.25 mg)

10 units (0.10 mL)

Once daily

Weeks 3–8

500 mcg (0.50 mg)

20 units (0.20 mL)

Weeks 9–12

Route: Subcutaneous injection, preferably near the site of injury. Preclinical research commonly uses 250–500 mcg per day for musculoskeletal applications[3][4]. For ≤10-unit (≤0.10 mL) administrations, consider 30- or 50-unit insulin syringes for improved readability.

BPC-157 Reconstitution Steps

Supplies Needed

Plan based on an 8–16 week combined protocol with the schedules above.

TB-500 Vials (5 mg each):

8 weeks ≈ 3 vials

12 weeks ≈ 4 vials

16 weeks ≈ 5 vials

BPC-157 Vials (5 mg each):

8 weeks ≈ 5 vials

12 weeks ≈ 7 vials

16 weeks ≈ 8 vials

Insulin Syringes (U-100):

8 weeks: 68 syringes (TB-500: 12 + BPC-157: 56)

12 weeks: 100 syringes (TB-500: 16 + BPC-157: 84)

16 weeks: 132 syringes (TB-500: 20 + BPC-157: 112)

Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.

8 weeks (8 total vials): 16 mL → 2 × 10 mL bottles

12 weeks (11 total vials): 22 mL → 3 × 10 mL bottles

16 weeks (13 total vials): 26 mL → 3 × 10 mL bottles